https://linearxdna.com/linear-dna-gene-therapy-boston-immuno-oncology-summit/2022-09-28T12:55:47-04:00https://linearxdna.com/apdn-forms-wholly-owned-subsidiary-linearx/2022-09-22T08:49:38-04:00https://linearxdna.com/with-new-spinoff-biotech-goes-all-in-on-dna-sales/2022-09-29T10:37:02-04:00https://linearxdna.com/linearx-joint-development-agreement-takis-evvivax/2023-09-13T14:52:48-04:00https://linearxdna.com/linearx-to-collaborate-with-italian-companies-takis-and-evvivax-on-cancer-vaccines/2022-10-05T17:48:51-04:00https://linearxdna.com/linearx-secures-new-rna-therapeutics-customers-for-contract-research-services/2022-10-05T17:44:05-04:00https://linearxdna.com/apdn-subsidiary-linearx-licenses-car-t-drug-candidate/2022-09-28T12:21:51-04:00https://linearxdna.com/non-viral-plasmid-free-car-t-manufacturing-platform-begins-preclinicals/2022-09-28T12:08:49-04:00https://linearxdna.com/linearx-putting-the-horsepower-behind-the-car-t/2022-10-05T17:41:31-04:00https://linearxdna.com/apdn-subsidiary-linearx-technogenetics-diagnostic-solutions/2022-09-22T08:15:45-04:00https://linearxdna.com/linearx-analyst-day-webinar-dna-vaccine-preclinical-data-in-licensed-car-t-therapy/2022-09-22T08:34:07-04:00https://linearxdna.com/linearx-takis-evvivax-linear-dna-cancer-vaccine-candidates/2023-09-13T14:24:32-04:00https://linearxdna.com/applied-dna-subsidiary-linearx-biotech-industry-first-anti-cd19-expression-human-car-t-cells/2022-09-22T08:21:49-04:00https://linearxdna.com/therapeutics-linear-dna/2022-09-28T11:48:42-04:00https://linearxdna.com/linearx-achieves-higher-expression-and-survival-rates-in-human-t-cells-transfected-non-virally-with-linear-dna/2022-09-28T11:46:04-04:00https://linearxdna.com/linearx-diagnostics-additional-assays/2022-06-20T14:36:19-04:00https://linearxdna.com/linearx-ships-dna-to-support-therapy-development-for-neurodegenerative-diseases/2022-06-20T14:35:57-04:00https://linearxdna.com/linearx-multiple-purchase-orders-linear-dna-therapeutic-development/2022-06-20T14:35:33-04:00https://linearxdna.com/linearx-acquires-vitatex/2022-10-05T17:34:40-04:00https://linearxdna.com/linearx-acquires-vitatex-2/2022-09-28T11:29:58-04:00https://linearxdna.com/medicare-coverage-of-car-t-cell-therapy-holds-positive-implications-for-linearx/2022-06-20T14:34:28-04:00https://linearxdna.com/applied-dna-new-blood-and-a-shot-in-the-arm/2022-09-28T11:19:12-04:00https://linearxdna.com/linearx-and-takis-evvivax-anti-cancer-vaccine-candidates-demonstrate-tumor-reduction/2022-06-20T14:33:51-04:00https://linearxdna.com/linear-dna-combo-shows-punch-in-cancer-fight/2022-09-28T11:09:40-04:00https://linearxdna.com/linearx-ictc-platform-prostate-cancer/2022-10-05T17:38:06-04:00https://linearxdna.com/lrx-14-customers/2023-09-13T14:51:59-04:00https://linearxdna.com/tyme-pancreatic-cancer-trial/2022-10-05T17:54:18-04:00https://linearxdna.com/linearx-signs-agreement-with-tyme-technologies/2022-10-05T17:47:42-04:00https://linearxdna.com/applied-dna-to-hold-investment-community-meetings-during-the-jp-morgan-38th-annual-healthcare-conference-and-present-at-the-biotech-showcase-2020/2023-09-13T14:49:59-04:00https://linearxdna.com/applied-dna-subsidiary-linearx-inc-sign-licensing-agreement-with-lifesensors-inc/2023-09-13T14:19:14-04:00https://linearxdna.com/coronoavirus-applied-dna-linearx-takis-biotech-vaccine/2023-09-13T14:15:57-04:00https://linearxdna.com/adnas-and-takis-biotech-partner-coronavirus-vaccine/2022-10-05T22:06:49-04:00https://linearxdna.com/applied-dna-coronavirus-countermeasures/2022-09-28T10:38:23-04:00https://linearxdna.com/applied-dna-sciences-updates-on-covid-19-collaboration-with-takis-biotech-4-preclinical-lineardna-vaccine-candidates-designed/2023-09-13T14:49:21-04:00https://linearxdna.com/applied-dna-speeds-coronavirus-vaccines-toward-tests/2022-10-05T17:24:57-04:00https://linearxdna.com/adnas-takis-biotech-covid-29-vaccine-candidates/2022-09-27T12:24:26-04:00https://linearxdna.com/stony-brook-firm-coronavirus-vaccine/2024-10-21T10:15:12-04:00https://linearxdna.com/coronavirus-preclinical-trials-italy-ministry-health/2023-09-13T14:48:43-04:00https://linearxdna.com/covid-diagnostics-kit/2023-09-13T14:48:25-04:00https://linearxdna.com/top-20-pharmaceutical-manufacturer-drug-development/2022-06-20T14:23:41-04:00https://linearxdna.com/applied-dna-ships-lineardna-to-another-development-customer/2023-09-13T14:48:03-04:00https://linearxdna.com/applied-dna-to-speak-on-covid-19-panel-at-maxim-groups-infectious-disease-virtual-conference-on-may-5/2023-09-13T14:47:36-04:00https://linearxdna.com/covid-preclinical-testing-apr-2020/2023-09-13T14:47:17-04:00https://linearxdna.com/covid-diagnostic-stony-brook-university/2023-09-13T14:46:55-04:00https://linearxdna.com/li-biotech-speeds-covid-19-vaccine-candidates-to-italy/2022-09-27T11:52:59-04:00https://linearxdna.com/italian-biotech-startup-developing-coronavirus-vaccine/2022-09-27T11:37:51-04:00https://linearxdna.com/applied-dna-takis-neutralizing-antibodies-may-2020/2023-09-13T14:46:37-04:00https://linearxdna.com/maxim-covid-19-virtual-conference/2023-09-13T14:46:21-04:00https://linearxdna.com/covid-19-vaccine-candidate-update/2023-09-13T14:45:17-04:00https://linearxdna.com/national-grid-grant-covid-19/2023-09-13T14:44:33-04:00https://linearxdna.com/company-also-secures-follow-on-order-from-existing-contract-research-customer-for-adoptive-cell-therapy-car-t-application/2023-09-13T14:41:37-04:00https://linearxdna.com/lineardna-feline-covid19-vaccine-trial/2024-10-21T10:44:19-04:00https://linearxdna.com/lineardna-non-viral-car-t-manufacturing/2023-09-13T14:36:49-04:00https://linearxdna.com/linearx-repeat-orders/2023-09-13T13:51:16-04:00https://linearxdna.com/beefing-up-cancer-treatments-with-a-vaccine-in-sight/2022-09-27T10:13:54-04:00https://linearxdna.com/spindle-biotech-mrna-production-system/2022-10-05T17:52:50-04:00https://linearxdna.com/positive-preclinical-data-for-lineardna-as-novel-cancer-vaccine-strategy/2024-10-21T10:14:10-04:00https://linearxdna.com/overcoming-the-dna-bottleneck/2022-09-22T08:24:10-04:00https://linearxdna.com/linear-dna-amplicons-novel-cancer-vaccine-strategy/2022-09-22T08:54:06-04:00https://linearxdna.com/applied-dna-and-evvivax-announce-publication-of-positive-preclinical-data-for-lineardna-platform-approach-to-cancer-immunotherapy/2023-09-13T14:35:35-04:00https://linearxdna.com/research-publication-demonstrates-utility-of-applied-dnas-lineardna-in-non-viral-car-t-manufacturing-systems/2023-09-13T14:36:02-04:00https://linearxdna.com/applied-dna-reports-veterinary-covid-19-vaccine-candidate-induces-neutralizing-antibodies-in-100-of-trial-cohort-against-b-1-1-7-p1-and-b-1-526-variants-and-sets-august-2021-mink-challenge-trial-lau/2023-09-13T14:38:43-04:00https://linearxdna.com/applied-dna-evvivax-and-gvs-receive-regulatory-approval-to-conduct-veterinary-clinical-trial-for-linear-covid-19-vaccine-candidate/2023-09-13T14:40:06-04:00https://linearxdna.com/apdn-and-takis-biotech-evvivax-to-launch-clinical-trial-for-veterinary-use-of-linear-covid-19-vaccine-candidate/2024-10-21T10:14:53-04:00https://linearxdna.com/applied-dna-positions-lineardna-platform-as-the-next-generation-manufacturing-platform-for-adeno-associated-virus-based-gene-therapies-through-new-patent-filing/2023-09-13T14:43:33-04:00https://linearxdna.com/applied-dna-and-takis-report-positive-preclinical-results-from-lineadna-vaccine-candidates-for-covid-19/2023-09-13T14:44:17-04:00https://linearxdna.com/linear-dna-veterinary-covid-19-vaccine/2024-10-21T10:14:44-04:00https://linearxdna.com/covid-19-vaccine-booster-felines/2024-10-21T10:14:17-04:00https://linearxdna.com/applied-dna-launches-initiatives-to-expand-awareness-of-lineardna-platform-as-an-alternative-to-plasmid-dna-for-therapeutic-applications-revamps-linearx-website/2023-09-13T14:35:10-04:00https://linearxdna.com/linearx-to-present-data-showcasing-advantages-of-its-enzymatically-produced-lineardna-as-substitute-for-plasmid-dna-in-ivt-mrna-production-at-the-2nd-annual-mrna/2023-09-13T13:49:22-04:00https://linearxdna.com/linearx-evvivax-positive-animal-proof-concept-data/2024-10-21T10:14:02-04:00https://linearxdna.com/the-future-of-rna-therapies-produced-with-lineardna-ivt-templates/2022-07-28T07:28:32-04:00https://linearxdna.com/lineardna-lnp-lipid-nanoparticles/2022-08-10T10:34:13-04:00https://linearxdna.com/applied-dna-cornell-university-college-veterinary-medicineresearch-collaboration/2023-09-13T14:34:38-04:00https://linearxdna.com/lineardna-vaccine-challenge-trial-ferrets/2023-09-13T13:46:03-04:00https://linearxdna.com/linear-dna-largest-purchase-order/2023-09-13T14:33:42-04:00https://linearxdna.com/apdn-to-establish-n-americas-1st-enzymatic-large-scale-cgmp-dna-manufacturing-capacity-in-new-york/2022-11-14T12:21:17-05:00https://linearxdna.com/apdn-announces-publication-of-peer-reviewed-journal-article-validating-potential-use-of-lineardna-as-a-new-class-of-dna-based-vaccines/2024-10-21T10:13:54-04:00https://linearxdna.com/lineardna-shipment-milestone/2023-03-29T10:51:50-04:00https://linearxdna.com/white-paper-next-generation-medication-the-therapeutic-potential-of-lineardna-delivered-via-lipid-nanoparticle/2023-06-15T07:34:24-04:00https://linearxdna.com/apdn-acquires-spindle-biotech/2023-09-13T14:33:05-04:00https://linearxdna.com/lrx-mrna-industry-conferences/2023-09-13T13:39:55-04:00https://linearxdna.com/beverly-wolgast-appointment/2023-09-13T14:32:31-04:00https://linearxdna.com/cornell-veterinary-high-value-animals/2024-10-21T10:13:26-04:00https://linearxdna.com/sarna-ivt-template-linea-dna-platform/2023-11-09T10:54:50-05:00https://linearxdna.com/linea-ivt-sarna-self-amplifying-mrna/2023-11-16T06:34:17-05:00https://linearxdna.com/cancer-diagnostic-application-repeat-order/2023-11-28T11:14:08-05:00https://linearxdna.com/applied-dna-announces-joint-development-agreement-to-integrate-linea-ivt-platform-into-cdmo-kudo-biotechnologys-mrna-manufacturing-workflow/2023-12-14T07:59:39-05:00https://linearxdna.com/jpm24-healthcare-conference-ir-bd-presentations/2024-01-08T12:23:14-05:00https://linearxdna.com/applied-dna-to-showcase-linea-dna-and-linea-ivt-platforms/2024-03-15T15:59:11-04:00https://linearxdna.com/alphazyme-linea-rnap-gmp-linea-ivt-production/2024-03-18T10:41:56-04:00https://linearxdna.com/hdt-bio-rapid-vaccine-development-program/2024-04-25T13:18:32-04:00https://linearxdna.com/institute-of-hematology-and-blood-transfusion-prague-apdn-linea-dna-car-t-cell-therapy/2024-05-13T10:20:33-04:00https://linearxdna.com/apdn-us-patent-covering-fundamental-aspect-of-its-linea-ivt-platform/2024-06-05T09:06:56-04:00https://linearxdna.com/alphazyme-linea-rnap-manufacturing-scale-up-project/2024-06-18T17:22:45-04:00https://linearxdna.com/reduction-dsrna-contamination-high-yield-mrna-production/2024-07-29T11:08:14-04:00https://linearxdna.com/linea-ivt-dsrna-contamination-poster-mrna-summit-2024/2024-07-29T11:58:17-04:00https://linearxdna.com/applied-dna-follow-on-order-cancer-diagnostic-ivds/2024-09-17T06:55:02-04:00https://linearxdna.com/linea-ivt-as-high-yield-dsrna-mitigated-platform-for-the-gmp-manufacture-of-rna/2024-09-17T09:35:57-04:00https://linearxdna.com/uhkt-phase-i-clinical-trial-car-t-cell-therapy-lineadna/2024-12-18T09:29:23-05:00https://linearxdna.com/applied-dna-buildout-gmp-facility-lineadna-ivt/2025-01-10T09:38:18-05:00https://linearxdna.com/jpm-2025-linearx-presentation/2025-01-17T11:22:02-05:00https://linearxdna.com/fast-tracking-mrna-medicines-synthetic-dna-platform-optimize-mrna-production/2025-01-22T15:30:33-05:00https://linearxdna.com/world-vaccine-congress/2025-03-12T14:38:25-04:00https://linearxdna.com/dna-process-dev-mfg-summit/2025-08-21T12:53:17-04:00https://linearxdna.com/4th-annual-circular-self-amplifying-rna-therapeutics-summit/2025-03-12T14:41:57-04:00https://linearxdna.com/5th-annual-mrna-based-therapeutics-summit/2025-03-12T14:40:07-04:00https://linearxdna.com/mrna-process-development-and-cmc-summit-2025/2025-06-04T11:02:21-04:00https://linearxdna.com/linearx-reshoring-drug-development-us-produced-synthetic-dna/2025-04-18T13:57:14-04:00https://linearxdna.com/linearx-frequently-asked-questions/2025-06-12T10:24:04-04:00https://linearxdna.com/apdn-sharpens-strategic-focus/2025-06-29T19:44:49-04:00https://linearxdna.com/apdn-follow-on-lineadna-order-ivd-manufacturer-cancer-diagnostic/2025-07-24T11:13:49-04:00https://linearxdna.com/dna-made-simple/2025-08-17T13:12:28-04:00https://linearxdna.com/lineaivt-better-rna-faster/2025-08-17T13:14:14-04:00https://linearxdna.com/4th-annual-mrna-process-development-cmc-summit/2025-09-18T13:35:34-04:00https://linearxdna.com/car-tcr-summit-2025/2025-09-18T13:16:48-04:00